Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Clinical Laboratory Techniques × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 3 Disease 2 Rectal Neoplasms 1 Pleural Effusion 1 Pleural Diseases 1 Pancreatitis, Chronic 1 Pancreatic carcinoma, familial 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Hereditary pancreatitis 1 Hematologic Diseases 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Bone Marrow Diseases 1

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Electrocardiography 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡